New Zealand markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
67.42-0.54 (-0.79%)
At close: 04:00PM EDT
66.96 -0.46 (-0.68%)
Pre-market: 08:13AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 99.10B
Enterprise value 107.73B
Trailing P/E 63.01
Forward P/E 29.94
PEG ratio (5-yr expected) 1.78
Price/sales (ttm)6.93
Price/book (mrq)5.14
Enterprise value/revenue 7.57
Enterprise value/EBITDA 31.26

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 331.91%
S&P500 52-week change 321.23%
52-week high 369.21
52-week low 348.35
50-day moving average 367.13
200-day moving average 357.45

Share statistics

Avg vol (3-month) 36.33M
Avg vol (10-day) 35.71M
Shares outstanding 51.47B
Implied shares outstanding 61.47B
Float 81.46B
% held by insiders 10.19%
% held by institutions 193.58%
Shares short (28 Mar 2024) 412.43M
Short ratio (28 Mar 2024) 42.01
Short % of float (28 Mar 2024) 40.85%
Short % of shares outstanding (28 Mar 2024) 40.85%
Shares short (prior month 29 Feb 2024) 49.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 306 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 11.18%
Operating margin (ttm)16.56%

Management effectiveness

Return on assets (ttm)4.47%
Return on equity (ttm)8.58%

Income statement

Revenue (ttm)14.24B
Revenue per share (ttm)9.80
Quarterly revenue growth (yoy)14.90%
Gross profit (ttm)N/A
EBITDA 3.61B
Net income avi to common (ttm)1.57B
Diluted EPS (ttm)1.07
Quarterly earnings growth (yoy)260.00%

Balance sheet

Total cash (mrq)865M
Total cash per share (mrq)0.59
Total debt (mrq)9.57B
Total debt/equity (mrq)48.99%
Current ratio (mrq)1.32
Book value per share (mrq)13.15

Cash flow statement

Operating cash flow (ttm)2.5B
Levered free cash flow (ttm)1.88B